Eli Lilly Takes Legal Action Against Unauthorized Sales of Experimental Drug

Eli Lilly announced on Wednesday that it has initiated six lawsuits against wellness vendors. These vendors are allegedly selling unauthorized versions of its experimental weight-loss drug, retatrutide. The company aims to curb the rising tide of illegal online sales of this potent drug.

A vial of Retatrutide photographed in Brooklyn, New York, highlights the ongoing issue. According to Eli Lilly, the unauthorized distribution of retatrutide by these vendors constitutes a significant problem, prompting the legal action.